Royce & Associates’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
BIP
Royce & Associates's PBH Position: Q2 2026 in Review
Royce & Associates reduced its Prestige Consumer Healthcare (PBH) stake by 76% in Q2 2026, selling an estimated $6.1M and leaving 38,440 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #626.
Royce & Associates first reported a position in PBH in Q2 2020 and has held it in 21 quarters since. The position peaked at $9.31M in Q1 2026. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Royce & Associates held 38,440 shares of Prestige Consumer Healthcare worth $1.82M as of Q2 2026.
- Royce & Associates sold 118,686 Prestige Consumer Healthcare shares in Q2 2026, an estimated $6.1M.
- Prestige Consumer Healthcare made up 0.01% of Royce & Associates's portfolio in Q2 2026, its #626 holding.
- Royce & Associates first reported a position in Prestige Consumer Healthcare in Q2 2020 and has held it in 21 quarters since.
- Royce & Associates's Prestige Consumer Healthcare position peaked at $9.31M in Q1 2026.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.